Key result
In STEMI complicated by cardiogenic shock, VA-ECMO combined with IABP was associated with higher survival compared to VA-ECMO alone (100% vs 55%; P=.04).
Why the study?
VA-ECMO increases afterload in the treatment of cardiogenic shock, and combining it with IABP has been suggested to reduce afterload and improve survival in STEMI.
Does combining VA-ECMO with IABP improve survival and neurological outcomes in patients with STEMI complicated by cardiogenic shock compared to VA-ECMO alone?
Population
18 STEMI patients with cardiogenic shock
Comparison
VA-ECMO + IABP vs VA-ECMO alone
Design
Multicenter in-hospital registry
Authors
Loading...
May support combined support in STEMI shock; leaves open randomized confirmation before practice change.
Cohort (n=18)
Yes
Does combining VA-ECMO with IABP improve survival and neurological outcomes in patients with STEMI complicated by cardiogenic shock compared to VA-ECMO alone?
Absolute Event Rate: 100% vs 55%
p-value: p=.04
In patients with STEMI complicated by cardiogenic shock, combining VA-ECMO with IABP was associated with significantly higher survival and better neurological outcomes compared to VA-ECMO alone, despite more complex coronary anatomy.
Brink et al. (2021) conducted a cohort in Cardiogenic shock in ST-elevation myocardial infarction (n=18). VA-ECMO + IABP vs. VA-ECMO alone was evaluated on Survival (p=.04). In STEMI complicated by cardiogenic shock, VA-ECMO combined with IABP was associated with higher survival compared to VA-ECMO alone (100% vs 55%; P=.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: